It has been validated that LINC00460 functions as a competing endogenous RNA (ceRNA) in co-expression and promotes the malignant development of multiple cancers, including prostate cancer (37), skin cancer (38), hepatocellular cancer (39), colorectal cancer (40) and so on, except for RCC. Here, LINC00460 is linked to Familial prostate cancer.